Cargando…

Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy

BACKGROUND: Angiogenesis, a process of generation of new blood vessels from the pre-existing vasculature, has been demonstrated to be a basic prerequisite for sustainable growth and proliferation of tumour. Anti-angiogenic treatments show normalization of tumour vasculature and microenvironment at l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yan, Zhang, Jie, Li, Zhiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259872/ https://www.ncbi.nlm.nih.gov/pubmed/28155728 http://dx.doi.org/10.1186/s12938-016-0275-x

Ejemplares similares

Computational Multi-Scale Modeling of Drug Delivery into an Anti-Angiogenic Therapy-Treated Tumor
por: Mohammadi, Mahya, et al.
Publicado: (2023)

The role of tumor microenvironment in resistance to anti-angiogenic therapy
por: Ma, Shaolin, et al.
Publicado: (2018)

Association between the exposure to anti-angiogenic agents and tumour immune microenvironment in advanced gastrointestinal stromal tumours
por: Yoo, Changhoon, et al.
Publicado: (2019)

Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
por: Schiffmann, Lars M., et al.
Publicado: (2022)

Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies
por: Yang, Zhengyang, et al.
Publicado: (2022)

Tumours modulate the systemic vascular response to anti‐angiogenic therapy
por: Hargreaves, Adam, et al.
Publicado: (2022)

Mathematical Modelling of a Brain Tumour Initiation and Early Development: A Coupled Model of Glioblastoma Growth, Pre-Existing Vessel Co-Option, Angiogenesis and Blood Perfusion
por: Cai, Yan, et al.
Publicado: (2016)

The role of angiogenic growth factors in the immune microenvironment of glioma
por: Ge, Zhengmao, et al.
Publicado: (2023)

Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma
por: Obad, Nina, et al.
Publicado: (2017)

Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
por: Grépin, Renaud, et al.
Publicado: (2010)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy
por: Khalili, Pariya, et al.
Publicado: (2021)

In silico mouse study identifies tumour growth kinetics as biomarkers for the outcome of anti-angiogenic treatment
por: Wu, Qianhui, et al.
Publicado: (2018)

Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021)

Robust positive control of tumour growth using angiogenic inhibition
por: Homayounzade, Mohamadreza, et al.
Publicado: (2023)

A Tunable Nanoplatform of Nanogold Functionalised with Angiogenin Peptides for Anti-Angiogenic Therapy of Brain Tumours
por: Naletova, Irina, et al.
Publicado: (2019)

The endogenous anti-angiogenic VEGF isoform, VEGF(165)b inhibits human tumour growth in mice
por: Rennel, E S, et al.
Publicado: (2008)

Anti-angiogenic therapy with contrast-enhanced ultrasound in colorectal cancer patients with liver metastasis
por: Wu, Zhiyong, et al.
Publicado: (2017)

The promise of anti-angiogenic cancer therapy
por: Oehler, M K, et al.
Publicado: (2000)

Biomarkers for Anti-Angiogenic Therapy in Cancer
por: Wehland, Markus, et al.
Publicado: (2013)

Anti-angiogenic therapies in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018)

Anti-angiogenic therapy for ovarian cancer
por: García García, Yolanda, et al.
Publicado: (2020)

Anti-angiogenic therapies in the management of glioblastoma
por: Schulte, Jessica D., et al.
Publicado: (2021)

AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR
por: Zhou, Yuanfeng, et al.
Publicado: (2012)

Changes in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapy
por: Vasudev, N S, et al.
Publicado: (2013)

Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules
por: Ho, Shu-Yi, et al.
Publicado: (2020)

Mathematical modelling of waves in multi-scale structured media
por: Movchan, Alexander B, et al.
Publicado: (2017)

Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer
por: Xu, Donghan, et al.
Publicado: (2023)

Anti-angiogenic therapy in ovarian cancer: current situation & prospects
por: Liu, Yinping, et al.
Publicado: (2021)

Future options of anti-angiogenic cancer therapy
por: Cao, Yihai
Publicado: (2016)

Recent Advances in Anti-Angiogenic Therapy of Cancer
por: Samant, Rajeev S., et al.
Publicado: (2011)

Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
por: Pircher, Andreas, et al.
Publicado: (2011)

Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
por: Nienhüser, Henrik, et al.
Publicado: (2017)

Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Trends and Challenges in Tumor Anti-Angiogenic Therapies
por: Jászai, József, et al.
Publicado: (2019)

Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
por: Haibe, Yolla, et al.
Publicado: (2020)

Revisiting anti-angiogenic therapy for recurrent glioblastoma
por: Peters, Katherine B.
Publicado: (2019)

Multi-parametric assessment of the anti-angiogenic effects of liposomal glucocorticoids
por: Kluza, Ewelina, et al.
Publicado: (2011)

Image-based modeling of vascular organization to evaluate anti-angiogenic therapy
por: Ascheid, David, et al.
Publicado: (2023)

Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy
por: Xiao, Mingshu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_viiam3k8mtukpttuc8smoudhap